The 2026 Integrative Medicine OCD Treatment Guide
- OCD is a neurological state, not a character trait.
- Intrusive thoughts and compulsions are driven by a brain circuit (the CSTC network) flooded with excitatory signals — a glutamate-GABA imbalance that neuroinflammation, gut dysbiosis, immune reactivity (including PANS/PANDAS in young people) and years of masking can all fuel.
- When first-line treatment fails, people are often wrongly told their OCD is “treatment-resistant”.
- The integrative approach addresses the biology alongside the psychology, across three pillars:
- Targeted low-dose medical cannabinoids for rapid relief.
- Bottom-up nervous system regulation.
- Functional medicine and neuronutrition to modulate glutamate, calm neuroinflammation and repair the gut.
- We see children, teenagers and adults.
The integrative medicine approach to OCD treatment
Integrative medicine treats OCD as what the biology now shows it to be — a whole-body, neurobiological condition rooted in brain circuitry, neurotransmitters and the immune system, not a behavioural habit or a failure of willpower. Rather than relying on exposure therapy alone to override the urges, it works to lower the underlying excitatory state that produces them: the glutamate-GABA imbalance, neuroinflammation, gut-brain-immune dysfunction and nervous system hyperarousal. This is the Integrative Medicine OCD Treatment Guide: what we commonly find when we assess someone properly, and what we most often see help — for children, teenagers and adults, including the biological drivers standard OCD care rarely investigates.
- What OCD is & why it’s mismanaged
- The hidden, exhausting toll of OCD
- The biology behind OCD
- Conditions that travel with OCD
- Functional medicine & testing
- Diet & the gut microbiome
- Medical cannabis for OCD
- Nervous system regulation
- Sleep & OCD
- Supplements & nutraceuticals
- Medication management
- Your environment & OCD
- OCD across the lifespan
- A patient journey
- Frequently asked questions
What OCD is, and why it’s so often mismanaged
Occasional intrusive thoughts are a normal part of human experience. OCD is what happens when those thoughts become relentless obsessions paired with unavoidable compulsions — a significant cognitive and physical toll that leaves many people in a state of chronic exhaustion. It is frequently accompanied by severe sleep disturbance, brain fog and gut symptoms, which standard care treats as separate problems rather than connected outputs of the same dysregulated system.
OCD is often mismanaged because standard care typically offers Exposure and Response Prevention (ERP) as the primary or sole intervention. ERP has an evidence base, but it asks people to sit with intense distress and resist all urges to self-soothe — without addressing the neurobiological state driving those urges in the first place. For neurodivergent people, this can be particularly difficult: rigid routines and a need for sameness are often a physiological attempt to manage sensory overload, not simply habits to be extinguished. And the physical and immune-mediated drivers of OCD — gut dysbiosis, neuroinflammation, immune reactivity — are almost never investigated. When first-line treatment fails, people are told their OCD is treatment-resistant, rather than recognised as having biology that needs a different approach.
The hidden, exhausting toll of OCD
The real cost of unaddressed OCD is not just the time lost to rituals — it is the sustained cognitive and physiological toll of a nervous system running on high alert. Mental bandwidth is consumed by obsessive loops, leaving little capacity for focused work, decisions or learning; routine tasks become effortful and exhausting; and the shame around rituals leads to concealment and isolation. For many high-performing adults and high-masking young people, OCD is managed in secret for years.
Over time this takes a heavy toll. Relationships strain under the time and energy OCD demands, secondary depression frequently develops as chronic exhaustion and social withdrawal build, and physical symptoms — gut distress, disrupted sleep, fatigue — compound the psychological burden while rarely being connected to the OCD itself. Treating OCD as the whole-body condition it is, rather than only its behavioural surface, is what breaks this cycle.
The biology behind OCD
OCD is rooted in neurobiology and immune function — not psychological weakness. Understanding the systems involved is what makes effective treatment possible:
CSTC circuitry and the glutamate-GABA imbalance
OCD is strongly linked to hyperconnectivity within the cortico-striato-thalamo-cortical (CSTC) network — a circuit that becomes structurally “stuck” because of an imbalance between excitatory glutamate and calming GABA. The brain is flooded with excitatory signals, making it biologically difficult to disengage from an obsessive thought or inhibit a compulsion. This is a neurological state, not a character trait.
Neuroinflammation and immune-mediated flares
OCD is frequently driven or amplified by systemic neuroinflammation and immune dysregulation; inflammatory cytokines can cross the blood-brain barrier and irritate the basal ganglia, central to OCD circuitry. In a subset of people — and especially children — immune-mediated responses in which autoantibodies attack neurological tissue after an infection (PANS/PANDAS) can trigger sudden, dramatic worsening of symptoms, almost overnight.
Gut-brain-immune dysfunction and masking debt
Specific gut bacteria metabolise glutamate and produce GABA, so a dysbiotic, inflamed gut creates a systemic excitatory state that fuels intrusive thoughts and compulsive loops. And for neurodivergent people, years of masking create a biological debt that keeps the autonomic nervous system in sustained sympathetic hyperarousal — directly worsening OCD severity and tolerance for uncertainty.
The conditions that travel with OCD
OCD rarely occurs in isolation, and the conditions it accompanies share its underlying biology. Treating them together is essential:
Autism, ADHD and AuDHD
OCD is common in neurodivergent people, and rigid, repetitive behaviours often serve a genuine regulatory function rather than being pure compulsions. Decades — or years — of masking drive the sympathetic hyperarousal that worsens OCD, which is why we manage these together and link to our neurodivergence pathway.
Anxiety, secondary depression & gut symptoms
Anxiety and OCD frequently overlap, secondary depression commonly develops from the chronic exhaustion and isolation, and gut distress, food intolerances and IBS-type symptoms are part of the same dysregulated gut-brain-immune picture.
PANS and PANDAS
In children and teenagers especially, a sudden, dramatic onset or worsening of OCD — often alongside tics or restrictive eating — can signal a post-infectious, immune-mediated (PANS/PANDAS) picture that needs a different, immune-focused workup rather than more of the same.
OCD and functional medicine testing
What we find
We identify the specific biochemical and immune roadblocks sustaining the neurobiological state that drives OCD, using advanced testing — stool, urine and hormone panels — to look for gut dysbiosis, markers relevant to the glutamate-GABA imbalance, immune reactivity, hidden infections relevant to PANS or PANDAS, and genomic factors affecting OCD.
What we commonly see work
Testing turns a “treatment-resistant” label into a data-led plan. Where an immune or infectious driver is found, it is addressed directly; where the gut or methylation is implicated, those become targets. Every test is chosen because the result will change the plan, and in children it is done as non-invasively as possible.
OCD diet and the gut microbiome
What we find
The gut is a key variable in OCD. Specific gut bacteria metabolise glutamate and produce GABA, so an inflamed or dysbiotic gut creates a systemic excitatory state that acts as continuous biological fuel for intrusive thoughts and compulsive loops. Blood-sugar swings and neuroinflammation add to the load.
What we commonly see work
Therapeutic dietary approaches are used to stabilise blood sugar, shift the gut-microbiota-brain axis and reduce neuroinflammation — with specific protocols for modulating glutamate and supporting methylation where indicated. Diets are tailored to the person (and, in children, to sensory food preferences), introduced gradually, and combined with gut-barrier repair and microbiome support, because calming the gut’s excitatory signalling directly reduces one of the drivers of OCD.
Medical cannabis for OCD
Medical cannabis is a legal medicine in the UK, available on private prescription from a specialist doctor. In OCD it is used as one targeted medical intervention within a wider plan — low-dose cannabinoid formulations that can provide relief within days to weeks, creating the biological bandwidth needed for the broader programme to take effect.
What we find
Because OCD is driven by an over-excitable nervous system, medicines that help calm that state can reduce the intensity of obsessions and compulsions and the physical hyperarousal that accompanies them. These formulations are well tolerated in most cases, including where standard medications have caused intolerable side effects.
What we commonly see work
Dosing is personalised, with separate daytime and evening formulations tailored to symptom patterns and individual sensitivities, and acute options for severe obsessive episodes where clinically indicated. For patients under 18, formulations are high-CBD and low-THC, taken as a specifically dosed oral tincture that does not cause impairment, and reserved for older teenagers with severe, treatment-resistant symptoms that have not responded to other approaches. Dr Dani Gordon, our medical director, is the UK’s most experienced cannabinoid medicine physician. Over-the-counter hemp CBD is not the same as prescribed medical cannabis.
Educational information about a specialist-prescribed treatment; not medical advice or a recommendation to use any specific medicine.
Nervous system regulation for OCD
What we find
Meaningful change in OCD requires reducing the underlying neurobiological excitatory state — not just managing the behavioural responses to it. A nervous system stuck in hypervigilance keeps producing the urgency behind obsessions and compulsions, which is why top-down, “think your way out of it” approaches so often fail on their own.
What we commonly see work
Our approach uses bottom-up physiological tools first, before adding any cognitive or brain-down techniques. We use non-invasive home neuromodulation devices to shift autonomic states, somatic body-up practices that use breath and body to engage the parasympathetic “rest and digest” system without requiring intense cognitive focus, and specialised audio-frequency programmes to reduce hypervigilance and build resilience to obsessive triggers over time. Only then do we add neurodivergent-adapted brain-down techniques such as modified mindfulness and compassion-focused therapy.
Sleep and OCD
What we find
Sleep is one of the most affected — and most overlooked — parts of OCD. Racing, obsessive thoughts make falling asleep difficult, night waking and unrefreshing sleep are common, and some people experience nocturnal panic or surges of adrenaline during the night. Poor sleep then feeds the daytime hyperarousal that drives the OCD, in a self-reinforcing loop.
What we commonly see work
Restoring sleep is a priority in its own right. We support it through nervous system regulation and evening somatic practices, sleep-focused environment and routine changes, evening cannabinoid formulations where appropriate, and by treating the excitatory and gut drivers that keep the brain “on” at night. Better sleep reliably lowers the baseline that OCD feeds on.
Supplements and nutraceuticals for OCD
What we find
Generic, single-ingredient supplements rarely touch OCD. What helps is a targeted, clinical-grade regimen chosen for the individual’s biology and symptom map — selected for synergistic effect rather than guessed from a symptom.
What we commonly see work
Matched to testing, nutraceutical support in OCD is aimed at:
- Modulating glutamate and supporting GABA balance
- Supporting methylation pathways where indicated
- Repairing the gut barrier and rebalancing the microbiome
- Calming neuroinflammation
- Supporting sleep and nervous system resilience
For children and teenagers, these are provided in child- and teen-friendly formats, and everything is used under medical guidance and reviewed as symptoms and biomarkers change.
Medication management for OCD
What we find
Standard OCD care leans on SSRIs and ERP, and when these do not work, people are often simply told their OCD is treatment-resistant. Many are also sensitive to medication side effects, and a higher dose of the same drug frequently isn’t the answer.
What we commonly see work
We address the neurobiological and immune drivers alongside the psychological dimension. Low-dose medical cannabinoids can create the biological bandwidth for the broader programme to work; any existing medication is managed carefully to reduce side effects; and where an immune or infectious driver such as PANS/PANDAS is identified, treatment is directed at that rather than at the surface behaviour. Everything is coordinated within one personalised plan and, in young people, matched to developmental stage.
Your environment and OCD
What we find
A hypervigilant nervous system is sensitive to its surroundings. Sensory overload, high-stimulation or high-pressure environments, and poor sleep settings all raise the baseline arousal that OCD feeds on — and for young people, the school environment can be a major trigger.
What we commonly see work
- Reducing sensory and environmental overload, with calm, low-stimulation spaces to reset in
- Protecting sleep with a consistent routine and a quiet, dark bedroom
- Working with, not against, a neurodivergent person’s need for predictability and sameness
- For children and teens, coaching parents and reducing pressure around school where it is a trigger
- Limiting evening screens and stimulation that keep the brain “on”
Lowering the environmental load helps the rest of the plan settle the excitatory state.
OCD across the lifespan
OCD presents differently at different ages, and we see children, teenagers and adults, tailoring the plan to the stage in front of us.
In children
In children, OCD is frequently hidden — concealed out of shame or an inability to articulate what is happening — and it reshapes the whole family’s daily life, structuring mealtimes, bedtimes and transitions around compulsions and often making school attendance difficult. A sudden or dramatic onset, especially alongside tics or restrictive eating, can point to PANS or PANDAS, which is rarely screened for in standard care. We use non-invasive functional testing, gut-brain-immune work, age-appropriate bottom-up nervous system regulation and parental support, addressing immune and infectious drivers directly where found — and we help parents who have often been wrongly told their child just needs more discipline or more exposure.
In teenagers
Highly masking teenagers are particularly likely to be missed, until years of suppressing their natural responses reach a tipping point and burnout, school refusal and a sharp worsening of OCD appear to arrive suddenly. For older teenagers with severe, treatment-resistant symptoms, low-dose high-CBD cannabinoid formulations may be used alongside gut, immune and nervous system work and neurodivergent-adapted therapy — always age-appropriate.
In adults
Many adults have managed OCD in secret for years, especially high performers and late-diagnosed neurodivergent people, by the time they reach us often exhausted and carrying secondary depression. Here the work is addressing the glutamate-GABA imbalance, neuroinflammation, gut and masking debt driving the OCD, alongside the psychological dimension, so the excitatory state settles and daily life opens back up. Our adult service sees patients aged 18 and over.
What an integrative plan can look like
Maya’s story
Maya, aged 16, was a high-achieving, quietly autistic teenager whose OCD had worsened sharply over a few months — intrusive contamination fears, hours of washing and checking, and a growing inability to get to school. She was barely sleeping, had frequent stomach aches, and had become withdrawn and low. A course of exposure therapy had left her more distressed, and her family had been told she needed to push through it or try a higher medication dose.
On assessment we recognised her rigid routines partly as attempts to manage sensory overload, and the fairly sudden worsening prompted a careful workup that, alongside functional testing, pointed to gut dysbiosis, immune reactivity and a possible post-infectious component. Rather than more exposure work first, we began bottom-up: home nervous system regulation and evening somatic practices to bring down the hyperarousal, sleep support, a gut and anti-inflammatory nutrition protocol with glutamate-modulating and methylation support, and — given the severity — a low-dose high-CBD oral tincture. The immune driver was addressed directly, and neurodivergent-adapted therapy was added once she was calmer.
Over the following months her sleep and stomach symptoms settled, the intensity of the obsessions eased, and the washing and checking gradually reduced. She was able to return to school part-time and then more fully, felt less ashamed and more understood, and her mood lifted as life opened back up.
Illustrative case based on the typical patient journey we see at the clinic; identifying details have been changed to protect privacy. Individual results vary.
Frequently asked questions
OCD responds to an integrative, whole-body approach that treats the biology driving it — the glutamate-GABA imbalance, neuroinflammation and gut-brain-immune dysfunction — alongside the psychological dimension. That means functional testing, gut and anti-inflammatory nutrition, targeted nutraceuticals, bottom-up nervous system regulation and low-dose medical cannabinoids, used alongside carefully managed medication and neurodivergent-adapted therapy.
Being told your OCD is “treatment-resistant” usually means the biological drivers haven’t been investigated. ERP asks you to resist urges without lowering the excitatory brain state producing them, which is why it can fail — especially for neurodivergent people. We look for and treat the underlying drivers first, then add adapted therapy.
For some people, yes. Low-dose medical cannabinoids can calm the over-excitable nervous system behind obsessions and compulsions and create the bandwidth for the wider plan to work, with day and night formulations. In under-18s they are high-CBD, low-THC, non-impairing, and reserved for severe, treatment-resistant cases. It is one option within a wider plan.
Possibly. A sudden or dramatic onset or worsening of OCD, often alongside tics or restrictive eating, can signal a post-infectious, immune-mediated picture (PANS/PANDAS) that is rarely screened for in standard care. We can assess for this and address immune and infectious drivers directly.
Yes — we see all ages. Children and teenagers are supported through our paediatric pathway (online, so no waiting room and no school missed), and adults through our adult service aged 18 and over, with treatment tailored to developmental stage and neurotype.
Integrative medicine, delivered by specialist doctors
- We treat the biology, not just the behaviour. The glutamate-GABA imbalance, neuroinflammation, gut-brain-immune drivers and masking debt behind OCD — alongside the psychological dimension.
- Bottom-up first. We lower the excitatory nervous system state before adding cognitive work, which is what makes therapy tolerable and effective.
- Immune-aware, including PANS/PANDAS. We screen for and address the immune and infectious drivers standard care overlooks.
- Specialist doctors, all ages, neurodiversity-affirming. Children, teenagers and adults, with care built around each person’s biology and neurotype.
Dr Dani Gordon, MD
Medical Director & Founder, London Resilience Clinic
Dr Dani Gordon, MD is a double board-certified medical doctor and world-leading authority in integrative medicine. She is the UK’s most experienced cannabinoid medicine doctor, a published researcher and author, with over 17 years of integrative and functional medicine experience treating complex chronic illness and neurodivergence — including ASD, ADHD, AuDHD and associated conditions — in children and adults.
UK General Medical Council (GMC) licence no. 7818491